Citations

Showing 1-2 of 2
Journal Article
Maganda, BA, OMS Minzi, E Ngaimisi, AAR Kamuhabwa, and E Aklillu. "CYP2B6* 6 genotype and high efavirenz plasma concentration but not nevirapine are associated with low lumefantrine plasma exposure and poor treatment response in HIV-malaria-coinfected patients." The pharmacogenomics journal 16, no. 1 (2016): 1-8.
Journal Article
Maganda, Betty A, Eliford Ngaimisi, Appolinary AR Kamuhabwa, Eleni Aklillu, and Omary MS Minzi. "The influence of nevirapine and efavirenz-based anti-retroviral therapy on the pharmacokinetics of lumefantrine and anti-malarial dose recommendation in HIV-malaria co-treatment." Malaria journal 14, no. 1 (2015): 179.
Showing 1-2 of 2